UK markets closed

Guanze Medical Information Industry (Holding) Co., Ltd. (2427.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.780+0.060 (+8.33%)
At close: 03:56PM HKT
Currency in HKD

Valuation measures4

Market cap (intra-day) 741.00M
Enterprise value 691.02M
Trailing P/E 24.19
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.42
Price/book (mrq)2.56
Enterprise value/revenue 4.12
Enterprise value/EBITDA 14.12

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 392.59%
S&P500 52-week change 322.55%
52-week high 31.050
52-week low 30.260
50-day moving average 30.901
200-day moving average 30.657

Share statistics

Avg vol (3-month) 3269.18k
Avg vol (10-day) 3278.5k
Shares outstanding 5950M
Implied shares outstanding 61.02B
Float 8237.9M
% held by insiders 174.96%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.02
Forward annual dividend yield 42.69%
Trailing annual dividend rate 30.02
Trailing annual dividend yield 32.64%
5-year average dividend yield 4N/A
Payout ratio 463.27%
Dividend date 3N/A
Ex-dividend date 404 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in CNY.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 17.66%
Operating margin (ttm)21.34%

Management effectiveness

Return on assets (ttm)7.56%
Return on equity (ttm)10.52%

Income statement

Revenue (ttm)156.07M
Revenue per share (ttm)0.16
Quarterly revenue growth (yoy)4.00%
Gross profit (ttm)N/A
EBITDA 44.34M
Net income avi to common (ttm)27.57M
Diluted EPS (ttm)0.030
Quarterly earnings growth (yoy)342.10%

Balance sheet

Total cash (mrq)68.44M
Total cash per share (mrq)0.07
Total debt (mrq)21.84M
Total debt/equity (mrq)8.08%
Current ratio (mrq)6.51
Book value per share (mrq)0.28

Cash flow statement

Operating cash flow (ttm)8.85M
Levered free cash flow (ttm)62.56M